GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Feng Chi Biotech Corp (ROCO:6744) » Definitions » EBITDA Margin %

Feng Chi Biotech (ROCO:6744) EBITDA Margin % : 20.17% (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Feng Chi Biotech EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Feng Chi Biotech's EBITDA for the six months ended in Jun. 2024 was NT$17.6 Mil. Feng Chi Biotech's Revenue for the six months ended in Jun. 2024 was NT$87.2 Mil. Therefore, Feng Chi Biotech's EBITDA margin for the quarter that ended in Jun. 2024 was 20.17%.


Feng Chi Biotech EBITDA Margin % Historical Data

The historical data trend for Feng Chi Biotech's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Feng Chi Biotech EBITDA Margin % Chart

Feng Chi Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial 16.88 22.29 20.24 19.02 19.29

Feng Chi Biotech Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.19 17.65 21.34 17.05 20.17

Competitive Comparison of Feng Chi Biotech's EBITDA Margin %

For the Biotechnology subindustry, Feng Chi Biotech's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Feng Chi Biotech's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Feng Chi Biotech's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Feng Chi Biotech's EBITDA Margin % falls into.



Feng Chi Biotech EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Feng Chi Biotech's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=34.838/180.578
=19.29 %

Feng Chi Biotech's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=17.586/87.2
=20.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Feng Chi Biotech  (ROCO:6744) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Feng Chi Biotech EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Feng Chi Biotech's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Feng Chi Biotech Business Description

Traded in Other Exchanges
N/A
Address
No. 5, Shaoxing North Street, 5th Floor-1, Zhongzheng District, Taipei City, TWN, 100
Feng Chi Biotech Corp provide promotion and support for clinical testing and molecular genetic medicine research related technologies. The company's products and services include clinical testing, food testing, newborn screening, prenatal screening, iron stomach, interscience, and colony counting.

Feng Chi Biotech Headlines

No Headlines